Baxter International Inc.

Baxter Healthcare Sa

Mark Nordhaus

Ton That Hai

Paul Jeffrey Sanders

Cong Jiang

Kent Lane Lurvey

Vadim V Krongauz

Tuan Bui

Ozlem Yardimci

David R Lamb

Lecon Woo

Sujatha Karoor

Birendra K Lal

Craig L Sandford

Shmuel Sternberg

Hsinjin E Yang

Robin Gail Pauley

Rosa Yeh

Robert A Clarke

Dustin Christopher Cawthon

Sivaramakrishnan Krishnamoorthy

Michael Tung-Kiung Ling

William S Hoerle

Ashok K Khanna

Alexander Savitski

Nicklaus J Kirichkow

Kenneth Glen Suh

Leo Martis

Ben Melnick

A method for immobilizing dyes and antimicrobial agents on a polymeric cover or housing for a medical device is disclosed and described. The surface may be that of a catheter, a connector, a drug vial spike, a bag spike, a prosthetic device, an endoscope, a surface of an infusion pump, a key pad, a touch screen or a handle. The surfaces may also be one or more of those associated with a infusion of a medicament or dialysis treatment, such as peritoneal dialysis or hemodialysis, where it is important that the working surface for the dialysis fluid be sterile. These surfaces include connectors for peritoneal dialysis sets or for hemodialysis sets, bag spikes, dialysis catheters, and so forth. A method for determining whether a surface has been sterilized, and a dye useful in so indicating, is also disclosed.

Antimicrobial housing and cover for a medical device

A medical device, such as a vascular access device, is disclosed for providing access to a medical fluid flow path for the introduction or withdrawal of medical fluids to and from the flow path. The access device includes an indicator for providing a visual indication when the access device has been exposed to an antiseptic agent.

Medical fluid access device with antiseptic indicator

Therapeutic compositions are provided. The compositions include a single molecule that can display both antioxidant and carbonyl trapping properties. This can effectively reduce inflammation, oxidative stress and carbonyl stress, such as to prevent and/or treat cardiovascular disease and inflammatory diseases in kidney disease patients.

Compositions capable of inhibiting reactive oxygen and carbonyl species

Methods of producing zirconium oxide compositions and using same are provided. The zirconium oxide compositions in crystalline form can be prepared by a synthetic process wherein the hydrolysis of zirconyl chloride and particle formation can be achieved simultaneously. Alternatively, the particle formation can occur first and then followed by hydrolysis with a base solution. The processes utilize a zirconyl salt solution that includes a zirconyl salt in isopropanol and water.

Method for processing a zirconium oxide composition in crystalline form

Growing community of inventors

Antioch, IL, United States of America

Mark Nordhaus